The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing macrophage cell therapy.

Total Raised

$13 M

Rounds

1

Links

Verticals

Biopharma
Biotechnology
Life Science

Investment History

  1. Series A

    Apr 2022

    $13M

Team

Amir Hefni

CEO

Simon Ramsden

CFO

Amol Ketkar

Chief Development Officer

Eli Gilsohn

VP, Intellectual Property